The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCAR-T 2019 | Expert discussion on CAR-T updates in lymphoma
Stephen Schuster, MD, Perelman Center for Advanced Medicine, Philadelphia, PA, Ian Flinn, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, MD, Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA, and Frederick Locke, MD, Moffitt Cancer Center, Tampa, FL, are featured in a roundtable discussion on CAR T-cell therapy in lymphoma at the 1st International Workshop on CAR-T, held in Miami, FL. The speakers primarily discuss relapsed diffuse large B-cell lymphoma (DLBCL), including the CAR-T cell therapies axicabtagene ciloleucel and tisagenlecleucel, and share their personal experiences with different CAR-T products, as well as their insights on the future directions of CAR-T in lymphoma.
